graphic - umbilical cord drug test, clinical toxicology testing, meconium drug test
 

Timely detection of in utero drug exposure is critical for effective detection and management of intoxication, withdrawal syndrome, and long-term social and medical needs of exposed neonates

Why Choose ARUP for Newborn Drug Testing?

  • Panels designed to meet your facility’s needs - ARUP’s neonatal drug testing options in meconium and umbilical cord tissue test for 45+ drugs and drug metabolites and are based on highly sensitive and specific qualitative liquid chromatography and tandem mass spectrometry (LC-MS/MS) for all analytes, eliminating the time-consuming immunoassay-based screen with reflex approach and potentially reduces costs by shortening the length of stay in the NICU.
  • Access to medical experts – When you partner with ARUP for your newborn drug testing needs, you gain access to our toxicology medical experts. They are here to assist with test selection that best suits your facility and interpretation of test results. These experts contribute to academic research and literature in this field and to decision support resources found at ARUP Consult: Newborn Drug Testing.
  • Value beyond the test*
    • Enhanced reports
    • Dashboards to track your facility’s drug positivity rates, and how they compare to national ARUP clients
      *Available upon request

Newborn Drug Testing Update, Meconium
Presented by Gwen McMillin, PhD, DABCC(CC,TC), FACC

Available Tests

Drug Detection Panel, Meconium, Qualitative (3004583)

Drug Detection Panel, Umbilical Cord Tissue, Qualitative (2006621)

Meconium and umbilical cord tissue are used to detect and document maternal drug use during the last trimester of a full-term pregnancy. ARUP’s neonatal drug testing in meconium and umbilical cord tissue is based on highly sensitive and specific qualitative liquid chromatography and tandem mass spectrometry (LC-MS/MS). In most cases, additional confirmation is not needed and allows for faster delivery of results.

For additional add-on tests, visit our Laboratory Test Directory.

Drugs and Drug Metabolites Reported

Opioids

Buprenorphine

Norbuprenorphine

Methadone

Methadone metabolite (EDDP)

Heroin metabolite (6-acetylmorphine)

Morphine

 

Codeine

Dihydrocodeine

Hydrocodone

Norhydrocodone

Hydromorphone

Oxycodone

 

Noroxycodone

Oxymorphone

Noroxymorphone (umbilical cord only)

Tramadol

N-desmethyltramadol

O-desmethyltramadol

 

Tapentadol

Meperidine

Fentanyl

Propoxyphene (umbilical cord only)

Naloxone

Stimulants

Methamphetamine

Amphetamine

MDMA (Ecstasy)

Methylphenidate (meconium only)

Cocaine

 

Phentermine

Cocaine metabolites:

Benzoylecgonine
m-Hydroxybenzoylecgonine
Cocaethylene

Sedatives/Hypnotics

7-aminoclonazepam

α-hydroxyalprazolam

α-hydroxymidazolam

Alprazolam

Butalbital

 

Clonazepam

Diazepam

Lorazepam

Midazolam

Nordiazepam

 

Oxazepam

Phenobarbital

Temazepam

Zolpidem

Other

Gabapentin

Phencyclidine (PCP)

Add-On Tests

Marijuana Metabolite, Umbilical Cord

Ethyl Glucuronide (Ethanol Biomarker), Umbilical Cord 

Marijuana Metabolite, Meconium

 

Chain of Custody May Not Be Required

Umbilical cord and meconium drug tests are performed to support clinical and social management decisions and do not usually require chain of custody.

If chain of custody is required, ARUP can provide a specimen tracking form to help authenticate the specimen collection and transport process, if desired. Contact ARUP Client Services for more information.

Additional Resources